SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-21-014720
Filing Date
2021-06-14
Accepted
2021-06-14 16:12:22
Documents
2
Period of Report
2019-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4A YEDID rdgdoc.html 4/A  
1 FORM 4A YEDID rdgdoc.xml 4/A 3949
2 yedidpoa.htm EX-24 9300
  Complete submission text file 0001437749-21-014720.txt   14953
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LIFESCI ADVISORS 250 WEST 55TH STREET, SUITE 3401 NEW YORK NY 10019
Business Address
Yedid Robert A. (Reporting) CIK: 0001792558 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35285 | Film No.: 211014737